| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |